![Sharon Barber-Lui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sharon Barber-Lui
Président chez
PURETECH HEALTH PLC
Fortune : 490 699 $ au 31/08/2026
Profil
Sharon Barber-Lui currently works at PureTech Health Plc, as Chairman from 2025, PureTech Health LLC, as Non-Executive Director from 2022, The American Institute of Certified Public Accountants, as Member, and Teva Pharmaceutical Industries Ltd., as Chief Financial Officer & Senior VP-North America from 2023.
Ms. Barber-Lui also formerly worked at Merck & Co., Inc., as Head-US Oncology Portfolio Market Strategy from 2019 to 2021, KPMG LLP, as Accountant, and EQRx, Inc., as Senior Vice President-Global Finance from 2022 to 2023.
Ms. Barber-Lui received her undergraduate degree in 2004 and Masters Business Admin degree in 2004 from Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PURETECH HEALTH PLC 0,12% | 29/07/2026 | 286 893 ( 0,12% ) | 490 699 $ | 31/08/2026 |
Postes actifs de Sharon Barber-Lui
| Sociétés | Poste | Début |
|---|---|---|
| PURETECH HEALTH PLC | Président | 08/07/2025 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/07/2023 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Directeur/Membre du Conseil | 01/03/2022 |
Anciens postes connus de Sharon Barber-Lui
| Sociétés | Poste | Fin |
|---|---|---|
| EQRX, INC. | Corporate Officer/Principal | 09/11/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2021 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | - |
Formation de Sharon Barber-Lui
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
